Difficulty: Medium
Average Score: 70%
Practice
A 29-year-old woman presents to her primary care physician for a regular yearly checkup. She has a history of a seizure disorder and has been taking an antiseizure medication for 8 years. She is also taking an oral contraceptive. She is in good health but complains that her gums seem to be overgrowing her teeth. Which of the following medications is likely responsible for her chief complaint?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Phenytoin. Phenytoin is known to cause gingival hyperplasia as a side effect, which is characterized by overgrowth of the gums. This adverse effect is often seen in patients who have been taking phenytoin for an extended period.
Option A) Estrogen analog and option D) Progesterone analog are unlikely to be responsible for the patient's gum overgrowth as they are not associated with this side effect.
Option B) Lamotrigine is a less likely cause of gingival overgrowth compared to phenytoin. While some antiseizure medications may have oral health side effects, lamotrigine is not typically associated with gingival hyperplasia.
Educationally, this question highlights the importance of recognizing medication side effects, especially in patients with complex medication regimens. It underscores the need for healthcare providers to be vigilant in monitoring for adverse effects and adjusting treatment plans accordingly to ensure optimal patient outcomes.
Option A) Estrogen analog and option D) Progesterone analog are unlikely to be responsible for the patient's gum overgrowth as they are not associated with this side effect.
Option B) Lamotrigine is a less likely cause of gingival overgrowth compared to phenytoin. While some antiseizure medications may have oral health side effects, lamotrigine is not typically associated with gingival hyperplasia.
Educationally, this question highlights the importance of recognizing medication side effects, especially in patients with complex medication regimens. It underscores the need for healthcare providers to be vigilant in monitoring for adverse effects and adjusting treatment plans accordingly to ensure optimal patient outcomes.